SCHEMBL6220883

SCHEMBL6220883

O=Cc1cc2c3ccccc3n(Cc3cc(Cl)ccc3Cl)c2cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VDR P11473 1/20 0.43
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
ALDH1A1 P00352 4/20 0.41
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
ALOX12 P18054 2/20 0.40
PTGER4 P35408 2/20 0.39
USP2 O75604 2/20 0.37
KDM4E B2RXH2 2/20 0.37
POLB P06746 1/20 0.37
TSHR P16473 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C9 P11712 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
CYP3A4 P08684 1/20 0.35
PMP22 Q01453 1/20 0.35
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6222458 0.84 VDR (0.40) VDRMEN1KMT2AALDH1A1LMNA
SCHEMBL6221701 0.83 SRC (0.43) VDRMEN1KMT2AALDH1A1LMNA
SCHEMBL6221700 0.83 SRC (0.43) VDRMEN1KMT2AALDH1A1LMNA
SCHEMBL27979862 0.83 KMT2A (0.55) MEN1KMT2AALDH1A1MAPTUSP2
SCHEMBL6222457 0.82 MEN1 (0.38) VDRMEN1KMT2AALDH1A1LMNA
SCHEMBL27979723 0.82 CYP19A1 (0.57) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL6221893 0.81 CYP1A2 (0.44) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL6221159 0.81 ALDH1A1 (0.41) MEN1KMT2AALDH1A1LMNAMAPT
Hydrochloric Acid SCHEMBL6222401 0.81 MAPT (0.38) VDRMEN1KMT2AALDH1A1LMNA
SCHEMBL6223026 0.81 MAPT (0.38) VDRMEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1137413-B1 NON-PEPTIDE ANTAGONISTS OF GLP-1 RECEPTOR AND METHODS OF USE AGOURON PHARMA (US) 2005-02-02 EP disclosed
US-6469021-B1 ANTAGONISTS OF THE INTESTINAL HORMONE GLUCAGONS-LIKE PEPTIDE 1 (GLP-1) HAVE A 9H-B-CARBOLINE CENTRAL MOTIF, FOR REGULATING THE SECRETION OF INSULIN IN DIABETIC PATIENTS AGOURON PHARMACEUTICALS, INC. 2002-10-22 US disclosed
EP-1137413-A4 NON-PEPTIDE ANTAGONISTS OF GLP-1 RECEPTOR AND METHODS OF USE AGOURON PHARMA (US) 2002-06-26 EP disclosed
EP-1137413-A2 NON-PEPTIDE ANTAGONISTS OF GLP-1 RECEPTOR AND METHODS OF USE AGOURON PHARMACEUTICALS, INC. (US) 2001-10-04 EP disclosed
WO-2000033839-A1 NON-PEPTIDE ANTAGONISTS OF GLP-1 RECEPTOR AND METHODS OF USE AGOURON PHARMACEUTICALS, INC. (US) 2000-06-15 WO disclosed